BeiGene raises RMB600M

Cancer company BeiGene Co. Ltd. (Beijing, China) raised RMB600 million ($96.6 million) in a venture round led by two of its existing investors: Hillhouse Capital and an undisclosed U.S. public investment fund. Also participating were existing investors including CITIC PE and undisclosed strategic and angel investors. They were joined by new investors Fidelity Management & Research; T. Rowe Price; Rock Springs Capital; and Boxer Capital of Tavistock Life Sciences. ...